It is disclosed which compositions contain at least one CD and one or more Chk1 inhibitors. There are also instructions on how to use a mixture of one or more Chk1 inhibitors and at least one CD to treat cancer or improve a cancer therapy. This evidence concerns the gene CHEK1 and cancer.